Home › NDC Lookup › RxCUI directory › RxCUI 284587

Valganciclovir 450 MG Oral Tablet [Valcyte] — RxCUI 284587

RxNorm drug concept · Semantic branded drug
RxCUI 284587 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI284587
Official nameValganciclovir 450 MG Oral Tablet [Valcyte]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asValcyte 450 MG Oral Tablet; Valcyte 450 MG (valganciclovir hydrochloride 496.3 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)55 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Valganciclovir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Valganciclovir is used for two main purposes. First, it treats a serious viral eye infection called CMV retinitis in adults living with AIDS. Second, it prevents a virus called CMV...
  • You really do need to take valganciclovir with food — it's not just a suggestion. Eating a meal when you take it increases the amount of active drug your body absorbs by a meaningf...
  • Do I have to take this with food, or can I take it on an empty stomach?
  • The most common ones are diarrhea, nausea, vomiting, fever, headache, and feeling tired. Shakiness (tremor) and trouble sleeping also happen fairly often. The ones your doctor real...
📖 Read our full Valganciclovir guide →

🕸️ Concept Web — How Valganciclovir 450 MG Oral Tablet [Valcyte] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Valganciclovir 450 MG Oral Tablet [Valcyte] RxCUI 284587

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Valganciclovir 275891
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Valcyte 304959
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Valganciclovir Oral Tablet 374656
    • Valganciclovir Oral Product 1163993
    • Valganciclovir Pill 1163994
    • Valganciclovir Oral Tablet [Valcyte] 368141
    • Valcyte Oral Product 1187139
    • Valcyte Pill 1187140
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Valganciclovir 450 MG Oral Tablet SCD · 313566
  • Valganciclovir 450 MG SCDC · 331565
  • Valganciclovir Oral Tablet SCDF · 374656
  • Valganciclovir Oral Product SCDG · 1163993
  • Valganciclovir Pill SCDG · 1163994

Brand-Name Concepts

  • Valganciclovir 450 MG [Valcyte] SBDC · 575014
  • Valganciclovir Oral Tablet [Valcyte] SBDF · 368141
  • Valcyte Oral Product SBDG · 1187139
  • Valcyte Pill SBDG · 1187140
  • Valcyte BN · 304959

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 284587 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61269-0480-60 1 BOTTLE, PLASTIC in 1 CARTON (61269-480-60) / 60 TABLET, F... Valcyte H2-Pharma, LLC 2001-03-29
61269-0485-10 1 BOTTLE, GLASS in 1 CARTON (61269-485-10) / 100 mL in 1 BO... Valcyte H2-Pharma, LLC 2009-08-28
Observed labelers: H2-Pharma, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.